Centre of Medical Law and Ethics, School of Law, King's College, London WC2R 2LS, UK.
Nat Rev Neurosci. 2011 Sep 20;12(10):603-12. doi: 10.1038/nrn3113.
There is widespread hope that the discovery of valid biomarkers for autism will both reveal the causes of autism and enable earlier and more targeted methods for diagnosis and intervention. However, growing enthusiasm about recent advances in this area of autism research needs to be tempered by an awareness of the major scientific challenges and the important social and ethical concerns arising from the development of biomarkers and their clinical application. Collaborative approaches involving scientists and other stakeholders must combine the search for valid, clinically useful autism biomarkers with efforts to ensure that individuals with autism and their families are treated with respect and understanding.
人们普遍希望能够发现有效的自闭症生物标志物,这不仅有助于揭示自闭症的病因,还能实现自闭症的早期诊断和更有针对性的干预。然而,人们需要认识到自闭症研究领域的这些新进展所面临的重大科学挑战,以及生物标志物的开发及其临床应用所引发的重要社会和伦理问题,从而对该领域的研究热潮加以适当控制。科学家和其他利益攸关方必须采取协作方式,将寻找有效且具有临床应用价值的自闭症生物标志物与确保自闭症患者及其家庭得到尊重和理解的努力结合起来。